These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24766271)

  • 1. Clinicopathological and prognostic impact of imaging of breast cancer angiogenesis and hypoxia using diffuse optical spectroscopy.
    Nakamiya N; Ueda S; Shigekawa T; Takeuchi H; Sano H; Hirokawa E; Shimada H; Suzuki H; Oda M; Osaki A; Saeki T
    Cancer Sci; 2014 Jul; 105(7):833-9. PubMed ID: 24766271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer detection of large size to DCIS by hypoxia and angiogenesis using NIRS.
    Nioka S; Shnall M; Conant E; Wang SC; Reynolds VB; Ching BC; Swan JHT; Chung PC; Cheng L; Shieh D; Lin Y; Chung C; Tseng SH; Chance B
    Adv Exp Med Biol; 2013; 789():211-219. PubMed ID: 23852497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Near-infrared optical imaging of cancer vascular remodeling after antiangiogenic therapy.
    Ueda S; Saeki T
    Breast Cancer; 2014 Nov; 21(6):776-9. PubMed ID: 24795075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical mammography: a new technique for visualizing breast lesions in women presenting non palpable BIRADS 4-5 imaging findings: preliminary results with radiologic-pathologic correlation.
    Athanasiou A; Vanel D; Fournier L; Balleyguier C
    Cancer Imaging; 2007 Feb; 7(1):34-40. PubMed ID: 17339139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fast 3D Near-infrared breast imaging using indocyanine green for detection and characterization of breast lesions.
    Schneider P; Piper S; Schmitz CH; Schreiter NF; Volkwein N; Lüdemann L; Malzahn U; Poellinger A
    Rofo; 2011 Oct; 183(10):956-63. PubMed ID: 21972043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical imaging of tumor vascularity associated with proliferation and glucose metabolism in early breast cancer: clinical application of total hemoglobin measurements in the breast.
    Ueda S; Nakamiya N; Matsuura K; Shigekawa T; Sano H; Hirokawa E; Shimada H; Suzuki H; Oda M; Yamashita Y; Kishino O; Kuji I; Osaki A; Saeki T
    BMC Cancer; 2013 Oct; 13():514. PubMed ID: 24176197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of diffuse optical spectroscopy in the clinical management of breast cancer.
    Shah N; Cerussi AE; Jakubowski D; Hsiang D; Butler J; Tromberg BJ
    Dis Markers; 2003-2004; 19(2-3):95-105. PubMed ID: 15096707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD133 expressionand clinicopathologic significance in benign and malignant breast lesions.
    Liu TT; Li XF; Wang L; Yang JL
    Cancer Biomark; 2020; 28(3):293-299. PubMed ID: 32390595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the chest wall on the measurement of hemoglobin concentrations by near-infrared time-resolved spectroscopy in normal breast and cancer.
    Yoshizawa N; Ueda Y; Nasu H; Ogura H; Ohmae E; Yoshimoto K; Takehara Y; Yamashita Y; Sakahara H
    Breast Cancer; 2016 Nov; 23(6):844-850. PubMed ID: 26474784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective study assessing the role of MRI in the diagnostic procedures for early breast carcinoma: a correlation of new foci in the MRI with tumor pathological features.
    Calvo-Plaza I; Ugidos L; Miró C; Quevedo P; Parras M; Márquez C; de la Cruz JJ; Suárez-Gauthier A; Pérez FJ; Herrero M; Marcos M; García-Aranda M; Hidalgo M; Estévez LG
    Clin Transl Oncol; 2013 Mar; 15(3):205-10. PubMed ID: 22872518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring neoadjuvant chemotherapy in breast cancer using quantitative diffuse optical spectroscopy: a case study.
    Jakubowski DB; Cerussi AE; Bevilacqua F; Shah N; Hsiang D; Butler J; Tromberg BJ
    J Biomed Opt; 2004; 9(1):230-8. PubMed ID: 14715078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR is/is not a useful diagnostic tool for breast cancer management.
    Van Goethem M; Verslegers I; Biltjes I; Parizel PM
    Acta Chir Belg; 2007 Jun; 107(3):267-70. PubMed ID: 17685251
    [No Abstract]   [Full Text] [Related]  

  • 13. MRI-guided diffuse optical spectroscopy of malignant and benign breast lesions.
    Ntziachristos V; Yodh AG; Schnall MD; Chance B
    Neoplasia; 2002; 4(4):347-54. PubMed ID: 12082551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging tumor vascularization for detection and diagnosis of breast cancer.
    Heijblom M; Klaase JM; van den Engh FM; van Leeuwen TG; Steenbergen W; Manohar S
    Technol Cancer Res Treat; 2011 Dec; 10(6):607-23. PubMed ID: 22066601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy.
    Cerussi A; Shah N; Hsiang D; Durkin A; Butler J; Tromberg BJ
    J Biomed Opt; 2006; 11(4):044005. PubMed ID: 16965162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of breast cancer.
    Watkins EJ
    JAAPA; 2019 Oct; 32(10):13-17. PubMed ID: 31513033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F-FDG PET/CT) in primary breast cancer.
    Ueda S; Tsuda H; Asakawa H; Shigekawa T; Fukatsu K; Kondo N; Yamamoto M; Hama Y; Tamura K; Ishida J; Abe Y; Mochizuki H
    Jpn J Clin Oncol; 2008 Apr; 38(4):250-8. PubMed ID: 18407934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective pilot clinical trial evaluating the utility of a dynamic near-infrared imaging device for characterizing suspicious breast lesions.
    Xu RX; Young DC; Mao JJ; Povoski SP
    Breast Cancer Res; 2007; 9(6):R88. PubMed ID: 18088411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Near-Infrared Diffuse Optical Imaging for Early Prediction of Breast Cancer Response to Neoadjuvant Chemotherapy: A Comparative Study Using 18F-FDG PET/CT.
    Ueda S; Yoshizawa N; Shigekawa T; Takeuchi H; Ogura H; Osaki A; Saeki T; Ueda Y; Yamane T; Kuji I; Sakahara H
    J Nucl Med; 2016 Aug; 57(8):1189-95. PubMed ID: 26940765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging in breast cancer: diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy.
    Tromberg BJ; Cerussi A; Shah N; Compton M; Durkin A; Hsiang D; Butler J; Mehta R
    Breast Cancer Res; 2005; 7(6):279-85. PubMed ID: 16457705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.